chitosan has been researched along with rabeprazole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gujarathi, NA; Patel, JK; Rane, BR | 1 |
| Ahmed, TA; El-Say, KM | 1 |
2 other study(ies) available for chitosan and rabeprazole
| Article | Year |
|---|---|
pH sensitive polyelectrolyte complex of O-carboxymethyl chitosan and poly (acrylic acid) cross-linked with calcium for sustained delivery of acid susceptible drugs.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acrylic Resins; Animals; Calcium; Calorimetry, Differential Scanning; Chitosan; Delayed-Action Preparations; Drug Carriers; Hydrogen-Ion Concentration; Intestinal Mucosa; Male; Mucins; Polyvinyls; Rabeprazole; Rats; Rats, Wistar; Spectroscopy, Fourier Transform Infrared | 2012 |
Development of alginate-reinforced chitosan nanoparticles utilizing W/O nanoemulsification/internal crosslinking technique for transdermal delivery of rabeprazole.
Topics: Administration, Cutaneous; Alginates; Animals; Chemistry, Pharmaceutical; Chitosan; Delayed-Action Preparations; Drug Delivery Systems; Emulsions; Glucuronic Acid; Hexuronic Acids; Kinetics; Male; Microscopy, Electrochemical, Scanning; Nanoparticles; Particle Size; Permeability; Rabeprazole; Rats; Rats, Wistar; Skin; Skin Absorption; Surface-Active Agents; Transdermal Patch | 2014 |